あなたのバッジ 52週レンジ $5–$9 92% of range アナリスト評価 STRONG BUY 9 analysts 目標株価 $9 +4% upside P/E 42.7 ROE 3.1% 純利益率 2.9%

MTLS 株価スナップショット 価格、時価総額、P/E、EPS、ROE、負債/資本、52週レンジ

03
株価 $8.50
P/E 42.7
EPS $0.13
収益 $268M
ROE 3.1%
52週レンジ $5–$9

MTLS 株価チャート 技術指標付きの日次 OHLCV — パン、ズーム、ビューのカスタマイズ

04
範囲
バー

バーの粒度は選択した期間に合わせて調整されます。バーの始値/高値/安値/終値を確認するにはチャートにカーソルを合わせてください。

Materialise NV - American Depositary Shares について Wikipediaからの企業概要

05 · wikidata

Materialise NV, headquartered in Leuven, Belgium, is a company in the 3D printing / additive manufacturing sector.

History

1990s

Materialise was founded in June 1990 by Wilfried Vancraen and his wife Hilde Ingelaere as a Rapid Prototyping service bureau. It was the first company of its kind in the Benelux region of Europe, through the acquisition of a single Stereolithography machine (the SLA 1).

In 1992, Materialise began mapping human anatomy digitally in three dimensions, using sliced CT image data, which lead to the development of its medical image processing software: Mimics. Concurrently, the team was also developing its industrial software solution, Magics. Both of these software solutions were later commercialized to promote growth.

In 1995, Materialise became the first company to produce 3D printed parts in more than one colour, specifically at this time for anatomical models produced using the stereolithography process to delineate the complexities of the anatomy (such as nerves, blood vessels and tumours) and allow surgeons to more precisely plan for operations.

The company developed and produced the first customised 3D printed surgical guide for a dental operation in 1996. These personalised guides were utilised during surgery to show surgeons bone cutting and drilling locations to apply implants. This knowledge was used to develop Materialise SimPlant software, allowing the surgeon to virtually plan the surgery and minimize invasive exploratory surgery.

The company launched one of the first 3D printing online ordering systems in 1997, Materialise NextDay, which later became Materialise OnSite. This service allowed 3D printing service customers to send digital 3D data, which could be printed and shipped the next day.

Demand for prototypes grew, leading Materialise to develop its Mammoth Stereolithography systems, which are capable of printing single-piece models with dimensions of more than 2 meters in the Y axis.

2000s

In the year 2000, hearing aid specialist Phonak approached Materialise to develop the Rapid Shell Modeling (RSM) software. This allowed the design process for customized, patient-specific hearing aid shells to become automated. The resulting designs could then be 3D printed to produce the customised hearing aids. This was the first high volume, end-use application of 3D printing, and today, 99% of the world's hearing aids are now produced using 3D printing.

Materialise acquired US company Columbia Scientific Inc, (CSI) in 2001, the creators of Sim/Plant and ImageMaster, which became the US headquarters for Materialise's dental division in that region.

In 2003 Materialise launched one of the first 3D printed consumer brands — .MGX by Materialise — for 3D printing end-use products as well as prototypes. In parallel, the company also acquired Fused Deposition Modelling (FDM) systems for industrial applications.

The following year, in 2004, Materialise introduced its 3-matic software, allowing 3D printer users to edit files directly in the STL format. Previously, if design changes were required in the digital model, designers had to make them in the CAD suite of choice before re-converting the entire file to STL again.

In 2006 Materialise launched RapidFit, developed as a 3D printed solution for shipping large parts with customized jigs and fixtures to prevent deformation or breakage while in transit.

In 2006 Materialise developed the first Titanium 3D printed skull implants, following the acquisition of OBL, which specialized in the creation of custom cranio-maxillfacial (CMF) implants, producing customized implants with intricate porous structures, that behave like natural bone and mimic its mechanical and thermal properties.

In 2008 Materialise introduced the e-Stage software which was the first software to automatically generate support structures for different geometries in Stereolitography. In the same year, the company launched i.materialise for the consumer market, making it possible for anyone to print their ideas using professional-quality equipment. Materialise also developed its first Build Processor to support running different 3D printing processes more efficiently within a single location.

2010s

In 2012, Materialise introduced Streamics to provide traceable quality control to industrial 3D printer users producing end-use parts within regulated industries.

Materialise went public on June 25, 2014 to enable expansion of its services and software development. The same year the company acquired OrthoView, a market leader in orthopaedic digital pre-operative planning software founded by Adrian Dwyer, John Chambers, and Peter Quinn, and officially established a new office in China in December with a focus on 3D printing Software and R&D, namely Materialise Shanghai Co. Ltd.

In 2016, the company opened a new and dedicated metal production facility in Bremen, Germany. Materialise HQ, Leuven, also acquired and started testing the multi jet fusion (MJF) process from HP. Production of parts with MJF started in the following year, 2017.

With the expansion of the AM Metal market, Materialise acquired ACTech in Germany to extend the company's metal capabilities, with a specific emphasis on low-volume production of highly complex metal parts. The acquisition also enabled Materialise to develop and improve its software suite for metal 3D printing.

== References ==

出典: Wikipedia (英語), CC BY-SA 4.0 · Wikipediaで表示 ↗

Wikidata ↗

セクターTechnology 業種Technology 従業員2,556 国BE

10年間のパフォーマンス 収益、純利益、利益率、EPSのトレンド

06
収益$268M
2016-12-31 → 2025-12-31
EPS$0.13
2016-12-31 → 2025-12-31
フリーキャッシュフロー$11M
2021-12-31 → 2025-12-31
純利益率2.9%
2017-12-31 → 2025-12-31
バリュエーションと指標 07–12

バリュエーション P/E、P/S、P/B、EV/EBITDA比率 — 株は割高か割安か?

指標 5年トレンド MTLS 5年平均 競合中央値 結論
P/E 42.75年平均 ≈3.4 ≈3.4 · ·

同業他社の中央値は、指標ごとに標準化された基準で計算されており、この銘柄に表示されているTTM/MRQ基準と常に一致するとは限りません。

バリュエーション · ≈ 5年平均 · 業界中央値 · 中央値に対する評価

決算履歴 EPS実績 vs 予想、サプライズ%、達成率、次回決算日

14
平均サプライズ 89.3%
期間レポートEPS ActualEPS 予想サプライズ
2026年6月30日 $0.07 $0.04 71.6%
2026年3月31日 $0.03 $0.01 194.1%
2025年12月31日 $0.11 $0.06 79.7%
2025年9月30日 $0.04 $0.01 292.2%
2025年6月30日 $0.00 $0.02 -100.0%
2024年12月31日 $0.05 $0.05 -2.0%

完全なファンダメンタルズ 年次別全指標 — 損益計算書、貸借対照表、キャッシュフロー

15
損益計算書 15
指標 トレンド 2025202420232022202120202019201820172016
Revenue $268M$267M$256M$232M$205M$170M$197M$185M$143M$114M
Cost of Revenue $115M$116M$111M$103M$87M$76M$87M$82M$63M$47M
Gross Profit $153M$151M$145M$129M$118M$94M$110M$102M$80M$68M
R&D Expense $46M$44M$38M$38M$27M$27M$23M$22M$20M$18M
Operating Income $9M$9M$6M$-3M$12M$-5M$7M$5M$392.0K$107.0K
Interest Expense $2M$1M$2M$2M$2M$2M$2M$2M$1M$665.0K
Interest Income $4M$8M$5M$6M$6M$2M$1M$4M$3M$2M
Pretax Income $7M$14M$7M$-1M$14M$-8M$4M$3M$-2M$-1M
Income Tax $-429.0K$733.0K$78.0K$975.0K$591.0K$-1M$3M$425.0K$522.0K$2M
Net Income $8M$13M$7M$-2M$13M$-7M$2M$3M$-2M$-3M
EPS (Basic) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04$-0.06
EPS (Diluted) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04$-0.06
Shares (Basic) 59,067,00059,067,00059,067,00059,064,00056,685,00053,364,00052,91549,80647,32547,325
Shares (Diluted) 59,072,00059,105,00059,085,00059,064,00056,843,00053,364,00053,98750,69747,32547,325
EBITDA $31M$9M$6M$-3M$12M$-5M$7M$5M$865.0K·
貸借対照表 10
指標 トレンド 2025202420232022202120202019201820172016
Cash & Equivalents $134M$102M$128M$141M$196M$112M$129M$116M$43M$56M
Inventory ··$17M$16M$11M$10M$13M$10M$11M$8M
Current Assets $224M$191M$206M$216M$258M$161M$191M$169M$97M$96M
PP&E (Net) $113M$111M$95M$94M$84M$88M$91M$93M$87M$45M
Goodwill $43M$43M$43M$44M$19M$19M$20M$17M$18M$9M
Intangibles $26M$30M$31M$38M$32M$33M$27M$26M$29M$10M
Total Assets $421M$396M$397M$411M$413M$326M$349M$313M$235M$162M
Current Liabilities $92M$102M$105M$106M$91M$84M$84M$73M$63M$48M
Retained Earnings $27M$19M$6M$-1M$965.0K$-7M$-272.0K$-2M$-4M$-2M
Stockholders' Equity $256M$249M$237M$229M$233M$133M$140M$136M$77M$79M
キャッシュフロー 8
指標 トレンド 2025202420232022202120202019201820172016
D&A $22M$22M$22M·······
Other Non-cash $-4M·········
Operating Cash Flow $25M$31M$20M$22M$26M$30M$28M···
CapEx $14M$25M$9M$22M$8M$11M$13M···
Investing Cash Flow $-10M$-29M$-11M$-54M$-13M$-28M$-26M···
Financing Cash Flow $17M$-28M$-22M$-23M$71M$-17M$11M···
Free Cash Flow $11M$7M$11M$680.0K$18M·····
Levered FCF $9M$6M$9M$-3M$16M·····
収益性 8
指標 トレンド 2025202420232022202120202019201820172016
Gross Margin 57.1%56.5%56.7%55.5%57.5%55.1%55.8%55.5%56.0%·
Operating Margin 3.3%3.5%2.2%-1.2%5.9%-2.7%3.6%2.8%0.61%·
Net Margin 2.9%5.0%2.6%-0.91%6.4%-4.2%0.84%1.6%-1.2%·
Pretax Margin 2.7%5.3%2.6%-0.51%6.7%-4.8%2.2%1.9%-0.79%·
EBITDA Margin 11.5%3.5%2.2%-1.2%5.9%-2.7%3.6%2.8%0.61%·
ROA 1.9%3.4%1.7%-0.51%3.6%-2.1%0.50%1.1%-0.83%·
ROE 3.1%5.5%2.9%-0.92%7.2%-5.2%1.2%2.8%-2.1%·
ROIC 3.7%3.6%2.4%-2.3%5.0%-3.1%2.0%3.3%0.58%·
流動性と支払能力 3
指標 トレンド 2025202420232022202120202019201820172016
Current Ratio 2.41.92.02.02.81.92.32.31.5·
Quick Ratio 1.51.01.21.32.11.31.51.60.7·
Interest Coverage 5.27.33.2-1.45.0-2.03.33.0-0.8·
効率性 2
指標 トレンド 2025202420232022202120202019201820172016
Asset Turnover 0.70.70.60.60.60.50.60.70.7·
Inventory Turnover ··6.77.58.26.77.77.8-6.5·
1株あたり 3
指標 トレンド 2025202420232022202120202019201820172016
Revenue / Share $4.53$4.51$4.33$3.93$3614.34$3194.08$3643.08$3649.96$3.01·
Cash Flow / Share $0.43$0.53$0.34$0.38$454.67·····
EPS (TTM) $0.13$0.23$0.11$-0.04$0.23$-0.13$0.03$0.06$-0.04·
バリュエーション(TTM) 4
指標 トレンド 2025202420232022202120202019201820172016
Revenue TTM $268M$267M$256M$232M$205M$170M$197M$185M$143M·
Net Income TTM $8M$13M$7M$-2M$13M$-7M$2M$3M$-2M·
P/E 42.730.659.7-220.0103.8-417.0610.3330.0-284.3·
Earnings Yield 2.3%3.3%1.7%-0.45%0.96%-0.24%0.16%0.30%-0.35%·

最新期間は左側 · null値は・として表示

財務諸表 損益計算書、貸借対照表、キャッシュフロー — 年次、過去5年間

16
指標 2025-12-312024-12-312023-12-312022-12-312021-12-31
収益 $268M $267M $256M $232M $205M
粗利益率 % 57.1% 56.5% 56.7% 55.5% 57.5%
営業利益率 % 3.3% 3.5% 2.2% -1.2% 5.9%
純利益 $8M $13M $7M $-2M $13M
希薄化後EPS $0.13 $0.23 $0.11 $-0.04 $0.23

機関投資家(13F) 66 提出者 · $57.8M合計 · 時点 2026年6月30日

17

四半期SECフォーム13Fでこの株式の保有を報告している機関。ロングポジションのみ。単一の提出者は、別々のオプションレッグで2回表示される場合があります。 大きな反対売買のプット/コール・レッグは、通常、マーケットメイクまたはヘッジされた在庫を反映しており、方向性への確信を示すものではありません。

保有者 66
保有価値 $57.8M
新規ポジション 7
解消済みポジション 9
機関投資家の動向 — Q2 2026 対 前四半期
新規ポジション 解消済みポジション 増加 減少 純株式数増減
7 (-4 前期比) 9 (+2 前期比) 15 (-1 前期比) 23 (+2 前期比) +519K

Q1 2026と比較しました。 SECフォーム13Fの提出期限は四半期末から45日後ですが、遅延提出者向けの短いバッファーが含まれます。この期間内の四半期は、直近で完全に報告されたペアを優先するためスキップされます。

機関投資家 評価額 株式数 % 追跡された13Fのうち タイプ
DISCIPLINED GROWTH INVESTORS INC /MN $14,803,837 1,992,441 25.60% 株式数
Rock Point Advisors, LLC $7,362,172 990,871 12.73% 株式数
Archon Capital Management LLC $5,696,001 766,622 9.85% 株式数
KING LUTHER CAPITAL MANAGEMENT CORP $4,671,613 628,750 8.08% 株式数
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $3,544,006 476,986 6.13% 株式数
ARK Investment Management LLC $3,118,995 419,784 5.39% 株式数
RENAISSANCE TECHNOLOGIES LLC $2,200,766 296,200 3.81% 株式数
CITADEL ADVISORS LLC $1,828,649 246,117 3.16% 株式数
EDMOND DE ROTHSCHILD HOLDING S.A. $1,486,052 200,007 2.57% 株式数
SUSQUEHANNA INTERNATIONAL GROUP, LLP $1,171,711 157,700 2.03% プットオプション
AMH Equity Ltd $1,156,672 207,661 2.00% 株式数
CREDIT AGRICOLE S A $1,120,184 150,765 1.94% 株式数
MORGAN STANLEY $1,110,153 149,415 1.92% 株式数
UBS Group AG $915,561 123,225 1.58% 株式数
TWO SIGMA INVESTMENTS, LP $746,916 100,527 1.29% 株式数
NANO CAP NEW MILLENNIUM GROWTH FUND L P $743,000 100,000 1.28% 株式数
AXA Investment Managers S.A. $636,250 114,228 1.10% 株式数
Quinn Opportunity Partners LLC $594,422 80,003 1.03% 株式数
MILLENNIUM MANAGEMENT LLC $500,069 67,304 0.86% 株式数
LPL Financial LLC $371,195 49,959 0.64% 株式数
Trexquant Investment LP $302,787 40,752 0.52% 株式数
XTX Topco Ltd $297,475 40,037 0.51% 株式数
MERITAGE PORTFOLIO MANAGEMENT $295,637 53,268 0.51% 株式数
SUSQUEHANNA INTERNATIONAL GROUP, LLP $278,313 37,458 0.48% 株式数
JANE STREET GROUP, LLC $268,810 36,179 0.46% 株式数
Engineers Gate Manager LP $257,992 34,723 0.45% 株式数
STATE STREET CORP $232,670 31,315 0.40% 株式数
TWO SIGMA ADVISERS, LP $229,770 41,400 0.40% 株式数
JANE STREET GROUP, LLC $219,928 29,600 0.38% コールオプション
Argos Wealth Advisors, LLC $217,090 29,218 0.38% 株式数
JPMORGAN CHASE & CO $211,943 29,601 0.37% 株式数
NewEdge Advisors, LLC $195,409 26,300 0.34% 株式数
GEODE CAPITAL MANAGEMENT, LLC $137,655 18,527 0.24% 株式数
AXQ CAPITAL, LP $118,390 15,934 0.20% 株式数
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92,132 12,400 0.16% コールオプション
Granite Investment Partners, LLC $87,050 11,716 0.15% 株式数
NEW YORK STATE COMMON RETIREMENT FUND $83,461 11,233 0.14% 株式数
QRG CAPITAL MANAGEMENT, INC. $80,801 10,875 0.14% 株式数
JANE STREET GROUP, LLC $75,786 10,200 0.13% プットオプション
Teton Advisors, LLC $74,300 10,000 0.13% 株式数
GAMMA Investing LLC $60,748 8,176 0.11% 株式数
Teton Advisors, Inc. $56,500 10,000 0.10% 株式数
RHUMBLINE ADVISERS $35,319 4,754 0.06% 株式数
Federation des caisses Desjardins du Quebec $26,048 3,508 0.05% 株式数
State of Tennessee, Department of Treasury $25,849 3,479 0.04% 株式数
OSAIC HOLDINGS, INC. $21,918 2,950 0.04% 株式数
BlackRock, Inc. $15,833 2,131 0.03% 株式数
ROYAL BANK OF CANADA $13,000 1,715 0.02% 株式数
CoreCap Advisors, LLC $9,288 1,250 0.02% 株式数
SIMPLEX TRADING, LLC $5,260 708 0.01% 株式数

66件の機関投資家をすべて表示 →

アクティビストおよび5%超のオーナー 1保有

18

SECスケジュール13Dを提出した投資家 — 発行体の影響を与える意図(アクティビストの保有、取締役会キャンペーン、M&A)を持つ5%超の受益権所有。各行は、その提出者のポジションの最新の既知の状態を示します。

提出者 提出済み 保有 ステータス 目的 提出書類
Wilfried Vancraen, Hilde Ingelaere, Idem ×5 提出書類 2025年10月30日 57.60% 修正 · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF保有状況 2のETFが保有

20

ウェイトは直接株式保有(N-PORT)のみを反映しています。レバレッジ型またはデリバティブベースのファンドは、表示されていない追加のスワップエクスポージャーを保有している可能性があります。

ファンド ウェイト 単位 時点 ソース
PRNT · ARK ETF Trust 3.70% 342,123 NS 2026年7月31日 N-PORT
BULD · Pacer Funds Trust 1.86% 43,572 NS 2026年7月31日 N-PORT

MTLS アナリストコンセンサス 強気・弱気のアナリストの見解、12ヶ月の目標株価、アップサイド

21
レーティング · 9 アナリスト 買い
中央値ターゲット $8.81 +3.6%
4 44.4% 強い買い
4 44.4% 買い
1 11.1% 保有
0 0.0% 売り
0 0.0% 強い売り

12ヶ月目標株価

3 アナリスト · 2026-09-30

平均値ターゲット $8.81 +3.6%

現在 現在価格 $8.50
安値$7.88 平均値$8.81 高値$9.73

マイ指標 あなた専用のウォッチリスト — 決算詳細から選択した行

26

重視する指標を選択してください — 上記の「財務諸表」の任意の行の横にある「+」をクリックしてください。

選択内容は保存され、すべてのティッカーで引き継がれます。

出典:SEC 20-F 提出日 4月 23, 2026